What Is Chronic Bronchitis?

Chronic bronchitis is clinically defined as the presence of productive cough (with sputum) on most days, for at least three consecutive months, over two consecutive years, after excluding other causes of chronic cough. It is one of the clinical phenotypes of chronic obstructive pulmonary disease (COPD).

It affects roughly 3-7% of adults, with a strong link to smoking — responsible for more than 80% of cases. Smoking causes chronic airway inflammation and submucosal-gland and goblet-cell hyperplasia, leading to mucus hypersecretion that obstructs the small airways.

Chronic bronchitis can exist with or without airflow obstruction. When it occurs with persistent obstruction on spirometry, it's classified as the bronchitic phenotype of COPD. The distinction matters because obstruction implies a different prognosis and the need for bronchodilator treatment.

1

Mucus Hypersecretion

Goblet-cell and submucosal-gland hyperplasia produces excess viscous mucus that obstructs the small airways and predisposes to infections.

2

Airway Inflammation

Chronic inflammation is predominantly neutrophilic, unlike the eosinophilic pattern of asthma. Neutrophils, macrophages, and CD8+ T lymphocytes dominate the inflammatory infiltrate.

3

Smoking as the Primary Cause

Smoking causes more than 80% of cases. Occupational exposure to dust and chemical vapors, along with air pollution, are other recognized causes.

Pathophysiology

Cigarette smoke and other inhaled irritants activate alveolar macrophages and epithelial cells, which release chemokines that recruit neutrophils to the airways. Neutrophils release elastase and metalloproteases that damage the epithelium and stimulate glandular hyperplasia.

The submucosal glands hypertrophy until they occupy more than 50% of the bronchial wall thickness (Reid index > 0.5). The goblet cells of the surface epithelium proliferate and extend into the distal bronchioles, where they are normally absent. The result is excessive mucus production with altered composition — more viscous and less transportable by the mucociliary system.

Normal versus bronchitic bronchus: glandular hyperplasia, raised Reid index, neutrophilic infiltrate, and mucus obstruction
Normal versus bronchitic bronchus: glandular hyperplasia, raised Reid index, neutrophilic infiltrate, and mucus obstruction

Mucociliary Dysfunction and Obstruction

The mucociliary system is the principal defense mechanism of the airways. In chronic bronchitis, the epithelial cilia are damaged by cigarette smoke — they become shorter, less numerous, and beat in an uncoordinated fashion. The viscous mucus accumulates, creating an environment favorable for bacterial colonization.

Obstruction of the small airways (bronchioles with a diameter less than 2 mm) is the earliest and most clinically important alteration. Peribronchiolar fibrosis, mucosal edema, and mucus plugging progressively reduce the caliber of these airways, contributing to air trapping and dyspnea.

Symptoms

The cardinal symptom of chronic bronchitis is productive morning cough. Patients frequently normalize the symptom, attributing it to smoking ("smoker's cough"), which delays diagnosis and treatment by years.

Symptoms of Chronic Bronchitis

  • Chronic productive cough

    Cough with mucoid to mucopurulent sputum, mostly in the morning. This is the defining symptom — present on most days for at least 3 months.

  • Abundant sputum

    Mucus production ranging from clear (stable phases) to yellow-greenish (infectious exacerbations). Volume can reach 60-100 mL per day.

  • Exertional dyspnea

    Progressive shortness of breath that first appears only with intense exertion and gradually limits everyday activities such as climbing stairs.

  • Intermittent wheezing

    Chest wheezing caused by airway narrowing from mucus and bronchospasm. It can mimic asthma, requiring differential diagnosis.

  • Fatigue and reduced functional capacity

    Chronic hypoxia and the increased work of breathing cause persistent fatigue and progressively limit activity.

  • Recurrent exacerbations

    Episodes of acute worsening with increased cough, purulent sputum, and dyspnea — often triggered by respiratory infections.

Diagnosis

The diagnosis is essentially clinical — chronic productive cough after exclusion of other causes (tuberculosis, bronchiectasis, lung cancer, heart failure). Spirometry is fundamental for detecting airflow obstruction and classifying severity.

Chest radiography may be normal or show peribronchial thickening ("tram tracks"). High-resolution CT is indicated when bronchiectasis or associated emphysema is suspected. The complete blood count may reveal polycythemia in cases of chronic hypoxia.

Diagnostic Criteria for Chronic Bronchitis

  1. Productive cough on most days, for at least 3 months, over 2 consecutive years
  2. Other causes of chronic cough ruled out (tuberculosis, cancer, bronchiectasis, CHF)
  3. Spirometry: may be normal (simple chronic bronchitis) or show obstruction (FEV1/FVC < 0.7)
  4. Chest radiography to exclude differential diagnoses
  5. Sputum culture when chronic bacterial colonization is suspected
3-7%
of the adult population is affected (estimate)
80%+
of cases are caused by smoking (estimate)
Up to ~50%
of long-term smokers develop chronic bronchitis over time
Variable
daily sputum volume in stable cases, which differs widely between patients

Differential Diagnosis

COPD

Chronic bronchitis with persistent obstruction (FEV1/FVC < 0.7 post-bronchodilator); progressive dyspnea

Bronchiectasis

Abundant purulent sputum, recurrent respiratory infections, CT showing irreversible bronchial dilation

Tuberculosis

Chronic cough, night sweats, weight loss, hemoptysis; sputum smear and culture mandatory when suspected

Bronchial Carcinoma

Smoker with a changed cough pattern, hemoptysis, weight loss, and hilar adenopathy; CT and bronchoscopy indicated

Heart Failure

Cough with pink or frothy sputum, orthopnea, edema, elevated BNP; can mimic chronic bronchitis in older adults

Bronchiectasis — An Underdiagnosed Condition

Bronchiectasis is a permanent, abnormal dilation of the bronchi caused by destruction of the bronchial walls, usually from recurrent infections or obstruction. It presents as a chronic productive cough with abundant mucopurulent sputum — easily confused with chronic bronchitis. A history of recurrent pneumonias since childhood, hemoptysis, and large-volume purulent sputum (often more than 30 mL per day) raises suspicion.

High-resolution chest CT (HRCT) is the test of choice and reveals the classic "tram-track" sign (a dilated bronchus with wall thickening). Treatment includes respiratory physiotherapy with bronchial drainage techniques, targeted antibiotics, and, in selected cases, surgical resection. The physician may prescribe physiotherapy as part of coordinated treatment.

Tuberculosis — Always Consider in Chronic Cough

Pulmonary tuberculosis must always be considered in the differential diagnosis of chronic productive cough, especially in patients who smoke, are immunocompromised, have had contact with diagnosed cases, or live in high-prevalence áreas. The classic triad — chronic cough lasting more than 3 weeks, weight loss, and night sweats — should raise suspicion even without hemoptysis.

Sputum smear (AFB search) and Mycobacterium tuberculosis culture are the reference tests. The rapid molecular test (GeneXpert) has high sensitivity and specificity. Chest radiography may show upper-lobe infiltrates with cavitation. Treatment is mandatory by law — the RHZE regimen for 6 months — with compulsory notification and contact tracing.

Bronchial Carcinoma — Surveillance in Smokers

Bronchial carcinoma is the leading cause of cancer mortality worldwide and occurs predominantly in smokers. Consider it in any smoker or former smoker with a changed cough pattern, new hemoptysis, unexplained weight loss, a persistent cough that doesn't respond to treatment, or a suspicious finding on chest radiography.

Screening with low-dose chest CT is indicated for high-risk smokers (more than 20 pack-years, aged 50 to 80, active or having quit less than 15 years ago) under national and international protocols. Early detection dramatically improves prognosis. Any new pulmonary nodule in a smoker requires systematic investigation with the specialist physician.

Treatment

Smoking cessation is the intervention with the best evidence for reducing disease progression and improving survival. All other therapies are complementary to this fundamental measure.

Smoking Cessation

Combines cognitive-behavioral therapy with pharmacotherapy (varenicline, bupropion, nicotine replacement therapy). Cessation reduces cough within weeks and normalizes mucociliary function within months.

Pharmacologic Treatment

Long-acting inhaled bronchodilators (LAMA such as tiotropium, LABA such as salmeterol) when obstruction is present. Mucoregulators (N-acetylcysteine, carbocysteine) may reduce exacerbations. Roflumilast serves as an anti-inflammatory in severe cases with frequent exacerbations.

Exacerbation Prevention

Annual influenza and pneumococcal vaccination. Low-dose macrolides (azithromycin 250 mg three times per week) reduce exacerbations in selected patients. Pulmonary rehabilitation improves functional capacity.

Complementary Approaches

Pulmonary rehabilitation with respiratory physiotherapy (bronchial drainage techniques), regular aerobic exercise, acupuncture as an adjunct, and managing comorbidities (gastroesophageal reflux, chronic sinusitis).

Do

  • Quit smoking: cessation reduces cough within weeks and normalizes mucociliary function within months
  • Keep up annual influenza and pneumococcal vaccination
  • Do regular aerobic exercise

Avoid

  • Treat the smoker's cough as normal and not needing treatment
  • Use cough syrups to treat chronic bronchitis: suppressing a productive cough may worsen secretion retention
  • Assume there is no point in quitting after so many years of smoking: quitting at any age helps
The essentials so far
  1. Smoking cessation is the intervention with the best evidence for reducing disease progression and improving survival.
  2. All other therapies are complementary to this fundamental measure.
  3. Long-acting inhaled bronchodilators are used when obstruction is present.
Continue: acupuncture as treatment

Acupuncture as Treatment

Acupuncture acts in chronic bronchitis through modulation of the cough reflex (via the vagus nerve), reduction of neutrophilic airway inflammation, regulation of mucus secretion, and improvement of mucociliary function. Electroacupuncture at thoracic and dorsal points appears to modulate the activity of the pulmonary autonomic nervous system.

Small, heterogeneous studies suggest that acupuncture may help relieve cough, sputum, and dyspnea in patients with stable chronic bronchitis, but the evidence is limited. Quality-of-life improvements have been reported, though the effect on pulmonary function is modest.

Acupuncture is an adjuvant therapy, not a substitute for pharmacologic treatment or smoking cessation. Some patients report relief of anxiety with acupuncture while quitting smoking, but the evidence for withdrawal symptoms is limited.

Prognosis

Prognosis in chronic bronchitis hinges on smoking cessation. Smokers who quit early, before age 40, better preserve pulmonary function, as the rate of decline returns closer to that expected in nonsmokers. Even quitting late slows progression and improves survival.

Simple chronic bronchitis (without obstruction) has a good prognosis once smoking stops — cough and sputum can disappear entirely within weeks to months. Chronic bronchitis with obstruction (COPD) has a guarded prognosis, with accelerated loss of pulmonary function.

Frequent exacerbations (2 or more per year) signal a poor prognosis, with accelerated decline in pulmonary function, worse quality of life, and higher mortality. Preventing exacerbations is a central therapeutic goal.

Simple chronic bronchitis

without obstruction
  • Spirometry can be normal
  • Has a good prognosis once smoking stops
  • Once smoking stops, cough and sputum can disappear entirely within weeks to months

Chronic bronchitis with obstruction

COPD
  • Spirometry shows obstruction (FEV1/FVC < 0.7)
  • Has a guarded prognosis, with accelerated loss of pulmonary function
  • Isn't curable, but can be treated to slow progression and control symptoms

Myths and Facts

Myth vs. Fact

Myth

Smoker's cough is normal and does not need treatment

Fact

The smoker's chronic cough is the first symptom of chronic bronchitis. Without smoking cessation, there is risk of progression to COPD with irreversible obstruction.

Myth

Chronic bronchitis only affects older adults

Fact

It can affect smokers as early as their 30s and 40s. Occupational exposure and pollution also cause chronic bronchitis in nonsmokers of any age.

Myth

After só many years of smoking, there is no point in quitting

Fact

Quitting smoking at any age helps. Cough and sputum improve within weeks, lung-function decline slows, and exacerbation risk drops.

Myth

Cough syrups treat chronic bronchitis

Fact

Antitussives suppress cough but do not treat inflammation. Productive cough clears mucus — suppressing it may worsen secretion retention.

Myth

Chronic bronchitis is the same thing as asthma

Fact

They are distinct diseases. Asthma has eosinophilic inflammation and reversible obstruction, whereas chronic bronchitis has neutrophilic inflammation and chronic mucus hypersecretion.

When to Seek Help

Any cough lasting more than 3 weeks warrants medical evaluation to rule out serious causes.

Frequently Asked Questions